Risk Factors Update Summary

• Risks associated with international operations increased due to complex international tax regulations and compliance requirements. This change might result in legal liabilities and additional costs.
• Identified material weaknesses in internal controls over financial reporting may lead to inaccurate financial statements.
• Changes in laws restricting the corporate practice of medicine could result in additional costs and inefficiencies. This change may have a significant impact on financial performance.
• Funding for bio surveillance monitoring activities from government contracts may be impacted by possible reductions.
• Failure to comply with state corporate practice of medicine laws may lead to penalties and disciplinary actions. This change could adversely affect business operations.
• Dependence on third parties for critical services, including compliance with laws, poses operational risks.
• Noncompliance with Nasdaq listing standards could result in delisting of common stock. This change may impact financial performance and reputation.
• Failure to comply with privacy laws or information security policies could lead to adverse impacts.
• Implementation of a Reverse Stock Split to regain compliance with Nasdaq listing rules. The effectiveness of this change is uncertain and dependent on various factors.
• Capital expenditures in new locations may not generate positive returns, impacting financial results.
• Anti-takeover provisions may delay or complicate third-party transactions. This change could affect the company's ability to respond to acquisition offers.
• Failure to comply with minimum airport standards could harm operations and financial condition.
• Scaled disclosure eligibility criteria updated based on public float and annual revenues. This change may impact the level of disclosure in SEC filings.
• Negative social media regarding various brands could lead to decreased revenues and customer engagement.